What Did This CEO Just Do with Personal Shares of Bruker Corp (NASDAQ: BRKR)?

By Carrie Williams

Today, the CEO & President of Bruker Corp (BRKRResearch Report), Frank Laukien, sold shares of BRKR for $16.59M.

This is Laukien’s first Sell trade following 84 Buy transactions. Following Frank Laukien’s last BRKR Sell transaction on June 19, 2018, the stock climbed by 10.8%.

See today’s analyst top recommended stocks >>

Based on Bruker Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $461 million and quarterly net profit of $30.8 million. In comparison, last year the company earned revenue of $432 million and had a net profit of $27 million. BRKR’s market cap is $6.5B and the company has a P/E ratio of 35.83. Currently, Bruker Corp has an average volume of 780K.

Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $45.00, reflecting a 7.7% upside.

The insider sentiment on Bruker Corp has been negative according to 22 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Frank Laukien’s trades have generated a 51.2% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments.